Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS

Establishing the metabolism pathway of the drug undergoing the hepatic biotransformation pathway is one of the most important aspects in the preclinical discovery process since the presence of toxic or reactive metabolites may result in drug withdrawal from the market. In this study, we present the...

Full description

Bibliographic Details
Main Authors: Maciej Gawlik, Vladimir Savic, Milos Jovanovic, Robert Skibiński
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Molecules
Subjects:
hlm
Online Access:https://www.mdpi.com/1420-3049/25/6/1367
id doaj-a58187ecd2a547cab7a7a95470ce8c57
record_format Article
spelling doaj-a58187ecd2a547cab7a7a95470ce8c572020-11-25T02:07:58ZengMDPI AGMolecules1420-30492020-03-01256136710.3390/molecules25061367molecules25061367Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MSMaciej Gawlik0Vladimir Savic1Milos Jovanovic2Robert Skibiński3Department of Medicinal Chemistry, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, PolandDepartment of Organic Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, SerbiaDepartment of Organic Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, SerbiaDepartment of Medicinal Chemistry, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, PolandEstablishing the metabolism pathway of the drug undergoing the hepatic biotransformation pathway is one of the most important aspects in the preclinical discovery process since the presence of toxic or reactive metabolites may result in drug withdrawal from the market. In this study, we present the structural elucidation of six, not described yet, metabolites of an antipsychotic molecule: molindone. The elucidation of metabolites was supported with a novel photocatalytical approach with the use of WO<sub>3</sub> and WS<sub>2</sub> assisted photochemical reactions. An UHPLC-ESI-Q-TOF combined system was used for the registration of all obtained metabolite profiles as well as to record the high resolution fragmentation spectra of the observed transformation products. As a reference in the in vitro metabolism simulation method, the incubation with human liver microsomes was used. Chemometric comparison of the obtained profiles pointed out the use of the WO<sub>3</sub> approach as being more convenient in the field of drug metabolism studies. Moreover, the photocatalysis was used in the direction of the main drug metabolite synthesis in order to further isolation and characterization.https://www.mdpi.com/1420-3049/25/6/1367photocatalysismetaboliteshlmmass spectrometrychemometric analysis
collection DOAJ
language English
format Article
sources DOAJ
author Maciej Gawlik
Vladimir Savic
Milos Jovanovic
Robert Skibiński
spellingShingle Maciej Gawlik
Vladimir Savic
Milos Jovanovic
Robert Skibiński
Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS
Molecules
photocatalysis
metabolites
hlm
mass spectrometry
chemometric analysis
author_facet Maciej Gawlik
Vladimir Savic
Milos Jovanovic
Robert Skibiński
author_sort Maciej Gawlik
title Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS
title_short Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS
title_full Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS
title_fullStr Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS
title_full_unstemmed Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS
title_sort mimicking of phase i metabolism reactions of molindone by hlm and photocatalytic methods with the use of uhplc-ms/ms
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2020-03-01
description Establishing the metabolism pathway of the drug undergoing the hepatic biotransformation pathway is one of the most important aspects in the preclinical discovery process since the presence of toxic or reactive metabolites may result in drug withdrawal from the market. In this study, we present the structural elucidation of six, not described yet, metabolites of an antipsychotic molecule: molindone. The elucidation of metabolites was supported with a novel photocatalytical approach with the use of WO<sub>3</sub> and WS<sub>2</sub> assisted photochemical reactions. An UHPLC-ESI-Q-TOF combined system was used for the registration of all obtained metabolite profiles as well as to record the high resolution fragmentation spectra of the observed transformation products. As a reference in the in vitro metabolism simulation method, the incubation with human liver microsomes was used. Chemometric comparison of the obtained profiles pointed out the use of the WO<sub>3</sub> approach as being more convenient in the field of drug metabolism studies. Moreover, the photocatalysis was used in the direction of the main drug metabolite synthesis in order to further isolation and characterization.
topic photocatalysis
metabolites
hlm
mass spectrometry
chemometric analysis
url https://www.mdpi.com/1420-3049/25/6/1367
work_keys_str_mv AT maciejgawlik mimickingofphaseimetabolismreactionsofmolindonebyhlmandphotocatalyticmethodswiththeuseofuhplcmsms
AT vladimirsavic mimickingofphaseimetabolismreactionsofmolindonebyhlmandphotocatalyticmethodswiththeuseofuhplcmsms
AT milosjovanovic mimickingofphaseimetabolismreactionsofmolindonebyhlmandphotocatalyticmethodswiththeuseofuhplcmsms
AT robertskibinski mimickingofphaseimetabolismreactionsofmolindonebyhlmandphotocatalyticmethodswiththeuseofuhplcmsms
_version_ 1724928488578744320